Staten Biotechnology
Founded Year
2014Stage
Other Investors | AliveAbout Staten Biotechnology
Staten Biotechnology develops technology and strategies for the prevention of cardiovascular events. Staten develops a human monoclonal antibody with an approach towards neutralizing apoC3 - a molecule in dyslipidemia managemen - which reduces triglyceride levels and increases the removal of atherogenic lipoprotein remnant particles.
Missing: Staten Biotechnology's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Staten Biotechnology's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Staten Biotechnology Patents
Staten Biotechnology has filed 10 patents.
The 3 most popular patent topics include:
- Molecular biology
- Biotechnology
- Virus families
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/13/2019 | 2/15/2022 | Molecular biology, Virus families, Biotechnology, Fatty acids, Immune system | Grant |
Application Date | 12/13/2019 |
|---|---|
Grant Date | 2/15/2022 |
Title | |
Related Topics | Molecular biology, Virus families, Biotechnology, Fatty acids, Immune system |
Status | Grant |
Latest Staten Biotechnology News
Jul 23, 2020
Staten Biotechnology, som Novo Nordisk i 2018 indgik partnerskab med, har indledt kliniske studier med et potentielt middel mod hjerte-kar-sygdom. En købsoption giver danskerne mulighed for senere at overtage det hollandske selskab. Novo Nordsik er trådt et skridt nærmere potentielt opkøb af det hollandske biotekselska Staten Biotechnology Foto: Tidsvilde Stine/Ritzau Scanpix
Staten Biotechnology Frequently Asked Questions (FAQ)
When was Staten Biotechnology founded?
Staten Biotechnology was founded in 2014.
Where is Staten Biotechnology's headquarters?
Staten Biotechnology's headquarters is located at Transistorweg 5J, Nijmegen.
What is Staten Biotechnology's latest funding round?
Staten Biotechnology's latest funding round is Other Investors.
Who are the investors of Staten Biotechnology?
Investors of Staten Biotechnology include Forbion Capital Partners and BioGeneration Ventures.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.